Pfizer (PFE)
Explora podcasts de análisis de resultados impulsados por IA Pfizer (PFE).
Suscribirse
Suscribirse
Recibe notificaciones de episodios
Recibe un email cuando se publiquen nuevos episodios de análisis de resultados de Pfizer.
Próximo episodio
La conferencia de resultados de Pfizer está programada para el 2 feb 2027 (antes de la apertura)
Nuevo episodio esperado el 3 feb 2027
Último episodio
Q3 2026 Resultados
7:16 • 11/3/2026
Todos los episodios
Q3 2026 Resultados
7:16Pfizer raised FY26 guidance ($62-64B revenue, $2.95-3.05 EPS) on strong non-COVID (+7%) and acquired growth (+32%), supported by advancing pipeline targeting high single-digit CAGR through 2033.
Q2 2026 Resultados
6:50Pfizer delivered Q2 2026 revenue of $15B (+1% YoY, +5% ex-COVID) with adjusted EPS of $0.77, raising full-year guidance by $500M while expanding cost savings to $9.7B through 2029.
Q1 2026 Resultados
8:25Pfizer delivered strong Q1 2026 results with $14.5B revenue and $0.75 adjusted EPS, driven by 22% growth in launched/acquired products and robust non-COVID performance, while reaffirming full-year guidance and highlighting pipeline progress in oncology and obesity.
Q4 2025 Resultados
8:32AI-generated analysis of PFE's Q4 2025 earnings call.
